Patents by Inventor Ronald K. Russell
Ronald K. Russell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9522931Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.Type: GrantFiled: May 18, 2012Date of Patent: December 20, 2016Assignee: Janssen Pharmaceutica NVInventors: Kenneth M. Wells, Ronald K. Russell, Xun Li, Shawn Branum, Derek A. Beauchamp, Sumihiro Nomura, Yosuke Matsumura
-
Patent number: 9434711Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: GrantFiled: July 2, 2014Date of Patent: September 6, 2016Assignee: Janssen Pharmaceutica, N.V.Inventors: Shawn T Branum, Raymond W Colburn, Scott L Dax, Christopher M Flores, Michele C Jetter, Yi Liu, Donald Ludovici, Mark J Macielag, Jay M Matthews, James J McNally, Laura M Andraka, Ronald K Russell, Ning Qin, Christopher Teleha, Kenneth M Wells, Scott C Youells, Mark A Youngman
-
Patent number: 9150532Abstract: The present invention comprises processes for preparing compounds of Formula (I). wherein: R0, R1, R2, R3, R4, R5, and A are as defined in the specification.Type: GrantFiled: July 24, 2014Date of Patent: October 6, 2015Assignee: JANSSEN PHARMACEUTICA NVInventors: Shawn Branum, Michael Reuman, Ronald K Russell, Christopher A. Teleha
-
Publication number: 20150080588Abstract: The present invention comprises processes for preparing compounds of Formula (I). wherein: R0, R1, R2, R3, R4, R5, and A are as defined in the specification.Type: ApplicationFiled: July 24, 2014Publication date: March 19, 2015Applicant: JANSSEN PHARMACEUTICA NVInventors: Shawn Branum, Michael Reuman, Ronald K. Russell, Christopher A. Teleha
-
Publication number: 20140315899Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: ApplicationFiled: July 2, 2014Publication date: October 23, 2014Inventors: Shawn T. Branum, Raymond W. Colburn, Scott L. Dax, Christopher M. Flores, Michele C. Jetter, Yi Liu, Donald Ludovici, Mark J. Macielag, Jay M. Matthews, James J. McNally, Laura M. Andraka, Ronald K. Russell, Ning Qin, Christopher Teleha, Kenneth M. Wells, Scott C. Youells, Mark A. Youngman
-
Patent number: 8809327Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: GrantFiled: February 28, 2012Date of Patent: August 19, 2014Assignee: Janssen Pharmaceutica, NVInventors: Shawn T. Branum, Raymond W. Colburn, Scott L. Dax, Christopher M. Flores, Michele C. Jetter, Yi Liu, Donald Ludovici, Mark J. Macielag, Jay M. Matthews, James J. McNally, Laura M. Reaney, Ronald K. Russell, Ning Qin, Christopher Teleha, Kenneth M. Wells, Scott C. Youells, Mark A. Youngman
-
Publication number: 20140206858Abstract: The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney.Type: ApplicationFiled: May 18, 2012Publication date: July 24, 2014Applicant: JANSSEN PHARMACEUTICA NVInventors: Kenneth M. Wells, Ronald K. Russell, Xun Li, Shawn Branum, Derek A. Beauchamp, Sumihiro Nomura, Yosuke Matsumura
-
Publication number: 20120190674Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: ApplicationFiled: February 28, 2012Publication date: July 26, 2012Inventors: Shawn T. Branum, Raymond W. Colburn, Scott L. Dax, Christopher M. Flores, Michele C. Jetter, Yi Liu, Donald Ludovici, Mark J. Macielag, Jay M. Matthews, James J. McNally, Laura M. Reaney, Ronald K. Russell, Ning Qin, Christopher Teleha, Kenneth M. Wells, Scott C. Youells, Mark A. Youngman
-
Patent number: 8153682Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: GrantFiled: July 18, 2008Date of Patent: April 10, 2012Assignee: Janssen Pharmaceutica, NVInventors: Shawn T. Branum, Raymond W. Colburn, Scott L. Dax, Christopher M. Flores, Michele C. Jetter, Yi Liu, Donald Ludovici, Mark J. Macielag, Jay M. Matthews, James J. McNally, Laura M. Reaney, Ronald K. Russell, Ning Qin, Christopher Teleha, Kenneth M. Wells, Scott C. Youells, Mark A. Youngman
-
Publication number: 20090264474Abstract: Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein A, B, G, Y, R1, R2, R3, and R4 are defined herein.Type: ApplicationFiled: July 18, 2008Publication date: October 22, 2009Inventors: Shawn T. Branum, Raymond W. Colburn, Scott L. Dax, Christopher M. Flores, Michele C. Jetter, Yi Liu, Donald Ludovici, Mark J. Macielag, Jay M. Matthews, James J. McNally, Laura M. Reaney, Ronald K. Russell, Ning Qin, Christopher Teleha, Kenneth M. Wells, Scott C. Youells, Mark A. Youngman
-
Patent number: 5310941Abstract: This invention relates to aminoethylthiophene derivatives and more particularly 2- and 3-aminoethylthiophene derivatives which are useful as antiarrhythmic agents, their methods of use as antiarrhythmic agents, and novel intermediate compounds useful for preparation of the aminoethylthiophene derivatives of the invention.Type: GrantFiled: January 13, 1993Date of Patent: May 10, 1994Assignee: Ortho Pharmaceutical CorporationInventors: Ronald K. Russell, Joseph J. Salata
-
Patent number: 5294621Abstract: This invention relates to thieno tetrahydropyridine and isoquinoline derivative compounds which are useful as antiarrhythmic agents, pharmaceutical compositions comprising such compounds, novel intermediates for their preparation and their methods of use. More particularly these thieno tetrahydropyridine and isoquinoline derivative compounds have been demonstrated to increase the effective refractory period (ERP) of isolated perfused cardiac tissue in vitro.Type: GrantFiled: October 7, 1992Date of Patent: March 15, 1994Assignee: Ortho Pharmaceutical CorporationInventor: Ronald K. Russell
-
Patent number: 5208252Abstract: This invention relates to aminoethylthiophene derivatives and more particularly 2-and 3-aminoethylthiophene derivatives which are useful as antiarrhythmic agents, their methods of use as antiarrhythmic agents, and novel intermediate compounds useful for preparation of the aminoethylthiophene derivatives of the invention.Type: GrantFiled: July 24, 1992Date of Patent: May 4, 1993Assignee: Ortho Pharmaceutical CorporationInventors: Ronald K. Russell, Joseph J. Salata
-
Patent number: 5112866Abstract: The synthesis of novel ethanesulfonamide compounds is described. The novel ethanesulfonamide compounds have antisecretory activity and are used in the treatment of peptic ulcer disease. The intermediates used to prepare the ethanesulfonamides are useful in the treatment of osteoporosis and other bone wasting diseases.Type: GrantFiled: August 14, 1989Date of Patent: May 12, 1992Assignee: Ortho Pharmaceutical CorporationInventor: Ronald K. Russell
-
Patent number: 5052888Abstract: A centrifugal fan includes a brushless d.c. motor, an impeller mounted on the motor and a scroll on which the motor is mounted. The scroll defines the air inlet and outlet and has an outer wall curved around the impeller to define a divergent air flow path. By truncating the scroll at the outlet substantially to eliminate any flat portions on the outer wall susceptible to mechanical vibrations at frequencies excited by the d.c. motor, a noise reduction is achieved. Further noise reduction may be achieved by resiliently mounting the motor on the scroll.Type: GrantFiled: July 11, 1990Date of Patent: October 1, 1991Assignee: IBM CorporationInventors: Ivor W. Bolton, David S. Gaunt, Ronald K. Russell
-
Patent number: 4939137Abstract: The synthesis of ring-fused thienopyrimidinedione derivatives is described. The novel ring-fused thienopyrimidinedione derivatives are generally vasodilating agents and antihypertensive agents and as such are useful as cardiovascular agents.Type: GrantFiled: June 28, 1989Date of Patent: July 3, 1990Assignee: Ortho Pharmaceutical CorporationInventors: Ronald K. Russell, Richard A. Rampulla
-
Patent number: 4874771Abstract: The synthesis of novel ethanesulfonamide compounds is described. The novel ethanesulfonamide compounds have antisecretory activity and are used in the treatment of peptic ulcer disease.Type: GrantFiled: September 6, 1988Date of Patent: October 17, 1989Assignee: Ortho Pharmaceutical CorporationInventor: Ronald K. Russell
-
Patent number: 4835157Abstract: Novel thienopyrimidine-2,4-dione piperidine derivatives and novel furo[3,4-d]pyrimidine-2,4-dione piperidine derivatives are described. The novel piperidine derivatives are selective serotonin antagonists and alpha adrenergic blocking agents with cardiovascular, gastrointestinal and central nervous system activites.Type: GrantFiled: March 15, 1988Date of Patent: May 30, 1989Assignee: Ortho Pharmaceutical CorporationInventors: Jeffery B. Press, Ronald K. Russell
-
Patent number: 4707550Abstract: The synthesis of thienopyrimidine-2,4-dione derivatives and their urea intermediates is described. The novel urea intermediates and thienopyrimidine-2,4-dione derivatives are general vasodilating agents and anti-hypertensive agents. The compounds are useful as cardiovascular agents.Type: GrantFiled: January 21, 1987Date of Patent: November 17, 1987Assignee: Ortho Pharmaceutical CorporationInventors: Jeffery B. Press, Ronald K. Russell
-
Patent number: 4670560Abstract: The synthesis of thienopyrimidine-2,4-dione derivatives and their urea intermediates is described. The novel urea intermediates and thienopyrimidine-2,4-dione derivatives are generally vasodilating agents and anti-hypertensive agents. The compounds are useful as cardiovascular agents.Type: GrantFiled: April 28, 1986Date of Patent: June 2, 1987Assignee: Ortho Pharmaceutical CorporationInventors: Jeffery B. Press, Ronald K. Russell